Global Injectable Nanomedicines Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

December 2018 | 118 pages | ID: GD7EE533567GEN
GlobalInfoResearch

Abstracts

SCOPE OF THE REPORT:

The global Injectable Nanomedicines market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Injectable Nanomedicines.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Injectable Nanomedicines market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Injectable Nanomedicines market by product type and applications/end industries.

Market Segment by Companies, this report covers

• Pfizer
• Johnson & Johnson
• Merck
• Roche
• Lupin
• Teva Pharmaceutical
• Bausch Health
• Celgene
• Amgen
• Pacira Pharmaceuticals

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Liposomes
• Micelles
• Nanocrystals
• Others

Market Segment by Applications, can be divided into

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others

Contents

1 INJECTABLE NANOMEDICINES MARKET OVERVIEW

1.1 Product Overview and Scope of Injectable Nanomedicines
1.2 Classification of Injectable Nanomedicines by Types
  1.2.1 Global Injectable Nanomedicines Revenue Comparison by Types (2017-2023)
  1.2.2 Global Injectable Nanomedicines Revenue Market Share by Types in 2017
  1.2.3 Liposomes
  1.2.4 Micelles
  1.2.5 Nanocrystals
  1.2.6 Others
1.3 Global Injectable Nanomedicines Market by Application
  1.3.1 Global Injectable Nanomedicines Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospitals
  1.3.3 Clinics
  1.3.4 Ambulatory Surgical Centers
  1.3.5 Others
1.4 Global Injectable Nanomedicines Market by Regions
  1.4.1 Global Injectable Nanomedicines Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Injectable Nanomedicines Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Injectable Nanomedicines Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Injectable Nanomedicines Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Injectable Nanomedicines Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Injectable Nanomedicines Status and Prospect (2013-2023)
1.5 Global Market Size of Injectable Nanomedicines (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Pfizer
  2.1.1 Business Overview
  2.1.2 Injectable Nanomedicines Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Pfizer Injectable Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
2.2 Johnson & Johnson
  2.2.1 Business Overview
  2.2.2 Injectable Nanomedicines Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Johnson & Johnson Injectable Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck
  2.3.1 Business Overview
  2.3.2 Injectable Nanomedicines Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Merck Injectable Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
2.4 Roche
  2.4.1 Business Overview
  2.4.2 Injectable Nanomedicines Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Roche Injectable Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
2.5 Lupin
  2.5.1 Business Overview
  2.5.2 Injectable Nanomedicines Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Lupin Injectable Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
2.6 Teva Pharmaceutical
  2.6.1 Business Overview
  2.6.2 Injectable Nanomedicines Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Teva Pharmaceutical Injectable Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
2.7 Bausch Health
  2.7.1 Business Overview
  2.7.2 Injectable Nanomedicines Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Bausch Health Injectable Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
2.8 Celgene
  2.8.1 Business Overview
  2.8.2 Injectable Nanomedicines Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Celgene Injectable Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
2.9 Amgen
  2.9.1 Business Overview
  2.9.2 Injectable Nanomedicines Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Amgen Injectable Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
2.10 Pacira Pharmaceuticals
  2.10.1 Business Overview
  2.10.2 Injectable Nanomedicines Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Pacira Pharmaceuticals Injectable Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL INJECTABLE NANOMEDICINES MARKET COMPETITION, BY PLAYERS

3.1 Global Injectable Nanomedicines Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Injectable Nanomedicines Players Market Share
  3.2.2 Top 10 Injectable Nanomedicines Players Market Share
3.3 Market Competition Trend

4 GLOBAL INJECTABLE NANOMEDICINES MARKET SIZE BY REGIONS

4.1 Global Injectable Nanomedicines Revenue and Market Share by Regions
4.2 North America Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
4.3 Europe Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
4.5 South America Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Injectable Nanomedicines Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA INJECTABLE NANOMEDICINES REVENUE BY COUNTRIES

5.1 North America Injectable Nanomedicines Revenue by Countries (2013-2018)
5.2 USA Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
5.3 Canada Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
5.4 Mexico Injectable Nanomedicines Revenue and Growth Rate (2013-2018)

6 EUROPE INJECTABLE NANOMEDICINES REVENUE BY COUNTRIES

6.1 Europe Injectable Nanomedicines Revenue by Countries (2013-2018)
6.2 Germany Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
6.3 UK Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
6.4 France Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
6.5 Russia Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
6.6 Italy Injectable Nanomedicines Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC INJECTABLE NANOMEDICINES REVENUE BY COUNTRIES

7.1 Asia-Pacific Injectable Nanomedicines Revenue by Countries (2013-2018)
7.2 China Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
7.3 Japan Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
7.4 Korea Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
7.5 India Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Injectable Nanomedicines Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA INJECTABLE NANOMEDICINES REVENUE BY COUNTRIES

8.1 South America Injectable Nanomedicines Revenue by Countries (2013-2018)
8.2 Brazil Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
8.3 Argentina Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
8.4 Colombia Injectable Nanomedicines Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE INJECTABLE NANOMEDICINES BY COUNTRIES

9.1 Middle East and Africa Injectable Nanomedicines Revenue by Countries (2013-2018)
9.2 Saudi Arabia Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
9.3 UAE Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
9.4 Egypt Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
9.5 Nigeria Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
9.6 South Africa Injectable Nanomedicines Revenue and Growth Rate (2013-2018)

10 GLOBAL INJECTABLE NANOMEDICINES MARKET SEGMENT BY TYPE

10.1 Global Injectable Nanomedicines Revenue and Market Share by Type (2013-2018)
10.2 Global Injectable Nanomedicines Market Forecast by Type (2018-2023)
10.3 Liposomes Revenue Growth Rate (2013-2023)
10.4 Micelles Revenue Growth Rate (2013-2023)
10.5 Nanocrystals Revenue Growth Rate (2013-2023)
10.6 Others Revenue Growth Rate (2013-2023)

11 GLOBAL INJECTABLE NANOMEDICINES MARKET SEGMENT BY APPLICATION

11.1 Global Injectable Nanomedicines Revenue Market Share by Application (2013-2018)
11.2 Injectable Nanomedicines Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Ambulatory Surgical Centers Revenue Growth (2013-2018)
11.6 Others Revenue Growth (2013-2018)

12 GLOBAL INJECTABLE NANOMEDICINES MARKET SIZE FORECAST (2018-2023)

12.1 Global Injectable Nanomedicines Market Size Forecast (2018-2023)
12.2 Global Injectable Nanomedicines Market Forecast by Regions (2018-2023)
12.3 North America Injectable Nanomedicines Revenue Market Forecast (2018-2023)
12.4 Europe Injectable Nanomedicines Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Injectable Nanomedicines Revenue Market Forecast (2018-2023)
12.6 South America Injectable Nanomedicines Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Injectable Nanomedicines Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Injectable Nanomedicines Picture
Table Product Specifications of Injectable Nanomedicines
Table Global Injectable Nanomedicines and Revenue (Million USD) Market Split by Product Type
Figure Global Injectable Nanomedicines Revenue Market Share by Types in 2017
Figure Liposomes Picture
Figure Micelles Picture
Figure Nanocrystals Picture
Figure Others Picture
Table Global Injectable Nanomedicines Revenue (Million USD) by Application (2013-2023)
Figure Injectable Nanomedicines Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Clinics Picture
Figure Ambulatory Surgical Centers Picture
Figure Others Picture
Table Global Market Injectable Nanomedicines Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Injectable Nanomedicines Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Injectable Nanomedicines Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Injectable Nanomedicines Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Injectable Nanomedicines Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Injectable Nanomedicines Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Injectable Nanomedicines Revenue (Million USD) and Growth Rate (2013-2023)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Injectable Nanomedicines Type and Applications
Table Pfizer Injectable Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Injectable Nanomedicines Type and Applications
Table Johnson & Johnson Injectable Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Injectable Nanomedicines Type and Applications
Table Merck Injectable Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Injectable Nanomedicines Type and Applications
Table Roche Injectable Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
Table Lupin Basic Information, Manufacturing Base and Competitors
Table Lupin Injectable Nanomedicines Type and Applications
Table Lupin Injectable Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Injectable Nanomedicines Type and Applications
Table Teva Pharmaceutical Injectable Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
Table Bausch Health Basic Information, Manufacturing Base and Competitors
Table Bausch Health Injectable Nanomedicines Type and Applications
Table Bausch Health Injectable Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
Table Celgene Basic Information, Manufacturing Base and Competitors
Table Celgene Injectable Nanomedicines Type and Applications
Table Celgene Injectable Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Injectable Nanomedicines Type and Applications
Table Amgen Injectable Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
Table Pacira Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Pacira Pharmaceuticals Injectable Nanomedicines Type and Applications
Table Pacira Pharmaceuticals Injectable Nanomedicines Revenue, Gross Margin and Market Share (2016-2017)
Table Global Injectable Nanomedicines Revenue (Million USD) by Players (2013-2018)
Table Global Injectable Nanomedicines Revenue Share by Players (2013-2018)
Figure Global Injectable Nanomedicines Revenue Share by Players in 2016
Figure Global Injectable Nanomedicines Revenue Share by Players in 2017
Figure Global Top 5 Players Injectable Nanomedicines Revenue Market Share in 2017
Figure Global Top 10 Players Injectable Nanomedicines Revenue Market Share in 2017
Figure Global Injectable Nanomedicines Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Injectable Nanomedicines Revenue (Million USD) by Regions (2013-2018)
Table Global Injectable Nanomedicines Revenue Market Share by Regions (2013-2018)
Figure Global Injectable Nanomedicines Revenue Market Share by Regions (2013-2018)
Figure Global Injectable Nanomedicines Revenue Market Share by Regions in 2017
Figure North America Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Europe Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
Figure South America Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
Table North America Injectable Nanomedicines Revenue by Countries (2013-2018)
Table North America Injectable Nanomedicines Revenue Market Share by Countries (2013-2018)
Figure North America Injectable Nanomedicines Revenue Market Share by Countries (2013-2018)
Figure North America Injectable Nanomedicines Revenue Market Share by Countries in 2017
Figure USA Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Canada Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Mexico Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
Table Europe Injectable Nanomedicines Revenue (Million USD) by Countries (2013-2018)
Figure Europe Injectable Nanomedicines Revenue Market Share by Countries (2013-2018)
Figure Europe Injectable Nanomedicines Revenue Market Share by Countries in 2017
Figure Germany Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
Figure UK Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
Figure France Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Russia Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Italy Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Injectable Nanomedicines Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Injectable Nanomedicines Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Injectable Nanomedicines Revenue Market Share by Countries in 2017
Figure China Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Japan Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Korea Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
Figure India Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
Table South America Injectable Nanomedicines Revenue by Countries (2013-2018)
Table South America Injectable Nanomedicines Revenue Market Share by Countries (2013-2018)
Figure South America Injectable Nanomedicines Revenue Market Share by Countries (2013-2018)
Figure South America Injectable Nanomedicines Revenue Market Share by Countries in 2017
Figure Brazil Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Argentina Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Colombia Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Injectable Nanomedicines Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Injectable Nanomedicines Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Injectable Nanomedicines Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Injectable Nanomedicines Revenue Market Share by Countries in 2017
Figure Saudi Arabia Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
Figure UAE Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Egypt Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
Figure Nigeria Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
Figure South Africa Injectable Nanomedicines Revenue and Growth Rate (2013-2018)
Table Global Injectable Nanomedicines Revenue (Million USD) by Type (2013-2018)
Table Global Injectable Nanomedicines Revenue Share by Type (2013-2018)
Figure Global Injectable Nanomedicines Revenue Share by Type (2013-2018)
Figure Global Injectable Nanomedicines Revenue Share by Type in 2017
Table Global Injectable Nanomedicines Revenue Forecast by Type (2018-2023)
Figure Global Injectable Nanomedicines Market Share Forecast by Type (2018-2023)
Figure Global Liposomes Revenue Growth Rate (2013-2018)
Figure Global Micelles Revenue Growth Rate (2013-2018)
Figure Global Nanocrystals Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Table Global Injectable Nanomedicines Revenue by Application (2013-2018)
Table Global Injectable Nanomedicines Revenue Share by Application (2013-2018)
Figure Global Injectable Nanomedicines Revenue Share by Application (2013-2018)
Figure Global Injectable Nanomedicines Revenue Share by Application in 2017
Table Global Injectable Nanomedicines Revenue Forecast by Application (2018-2023)
Figure Global Injectable Nanomedicines Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Clinics Revenue Growth Rate (2013-2018)
Figure Global Ambulatory Surgical Centers Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Figure Global Injectable Nanomedicines Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Injectable Nanomedicines Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Injectable Nanomedicines Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Injectable Nanomedicines Revenue Market Forecast (2018-2023)
Figure Europe Injectable Nanomedicines Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Injectable Nanomedicines Revenue Market Forecast (2018-2023)
Figure South America Injectable Nanomedicines Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Injectable Nanomedicines Revenue Market Forecast (2018-2023)